Index
A
Adenine, 251
Alternating DSC (ADSC), 189–94
Antifungals, 327
fluconazole, 328
leucinostatin A, 327
Antimicrobial agents, 305
classification, 306
mechanism of action, 315–25
natural and synthetic antimicrobial agents, 315
analogs of cathelicidin, 322
gramicidin S, 321
lactoferrampin, 324
lycotoxins, 323
PGLa (peptide-Gly-Leuamide), 321
polyphemusin, 320
protegrin–1, 321
PV5, a variant of polyphemusin, 320
side effects on eukaryotic biomembrane models, 310–13
synthetic antimicrobial agents, 312
aminoglycosides (spectinomycin and streptomycin), 313
brodimoprim, 312
ofloxacin, 312–13
sulfadiazine, 314
tobramycin, 313
trimethtropin, 312
Antivirals, 325
FP31 (31-residue synthetic peptide), ...
Get Drug-Biomembrane Interaction Studies now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
